Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: [18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice

Figure 3

PET/CT images.Representative combined PET/CT images of [18F]FLT scans (upper panel) and [18F]FDG scans (lower panel) of mice treated with belinostat (40 mg/kg ip twice daily Day 0–4 and 6–10) or vehicle respectively. Tracer uptake was measured in the same animals at baseline, Day 3, Day 6 and Day 10. Dotted circles indicate the tumors.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us